InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Henwood Geraldine, Chief Executive Officer. Director active across 1 company, notably Baudax Bio, Inc.. Aggregated, 6 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €11k. History available since 7 May 2021. The latest transaction was filed on 15 December 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
HENWOOD GERALDINE serves as President and CEO at Baudax Bio, Inc. She is responsible for the strategic direction of the company and the management of its daily operations. Under her leadership, Baudax Bio is committed to developing innovative treatments for patients. HENWOOD GERALDINE plays a crucial role in defining the company's vision and establishing strong relationships with investors and partners.